Avita Medical Inc (AVH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avita Medical Inc (AVH) has a cash flow conversion efficiency ratio of 0.411x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.32 Million ≈ $-3.77 Million USD) by net assets (AU$-12.96 Million ≈ $-9.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Avita Medical Inc (AVH) market capitalisation for the company's overall valuation and market capitalisation.
Avita Medical Inc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Avita Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Avita Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avita Medical Inc ranked by their cash flow conversion efficiency. Explore AVH cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Songwon Industrial
KO:004430
|
0.010x |
|
Lotte Chemical Titan Holding BHD
KLSE:5284
|
-0.040x |
|
Olimpo Real Estate SA
MC:YORE
|
0.026x |
|
Petronor E&P Ltd
OL:PNOR
|
-0.047x |
|
Urbana Corporation
TO:URB-A
|
-0.006x |
|
Foraco International SA
TO:FAR
|
-0.094x |
|
Capstone Energy Plus, Inc. Common Stock
NASDAQ:CEPL
|
0.182x |
|
Oyak Yatirim Menkul Degerler AS
IS:OYYAT
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Avita Medical Inc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Avita Medical Inc from 1994 to 2025. View Avita Medical Inc share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$4.50 Million ≈ $3.18 Million |
AU$-48.94 Million ≈ $-34.63 Million |
-10.878x | -1303.85% |
| 2024-06-30 | AU$49.06 Million ≈ $34.71 Million |
AU$-38.01 Million ≈ $-26.90 Million |
-0.775x | -243.95% |
| 2023-06-30 | AU$124.47 Million ≈ $88.07 Million |
AU$-28.04 Million ≈ $-19.84 Million |
-0.225x | -33.48% |
| 2022-06-30 | AU$147.08 Million ≈ $104.07 Million |
AU$-24.82 Million ≈ $-17.56 Million |
-0.169x | +46.28% |
| 2021-06-30 | AU$72.40 Million ≈ $51.23 Million |
AU$-22.75 Million ≈ $-16.09 Million |
-0.314x | 0.00% |
| 2020-06-30 | AU$104.91 Million ≈ $74.23 Million |
AU$-32.96 Million ≈ $-23.32 Million |
-0.314x | +65.95% |
| 2019-06-30 | AU$20.86 Million ≈ $14.76 Million |
AU$-19.25 Million ≈ $-13.62 Million |
-0.923x | +26.32% |
| 2018-06-30 | AU$13.98 Million ≈ $9.89 Million |
AU$-17.51 Million ≈ $-12.39 Million |
-1.252x | +25.05% |
| 2017-06-30 | AU$5.12 Million ≈ $3.62 Million |
AU$-8.56 Million ≈ $-6.05 Million |
-1.671x | -44.22% |
| 2016-06-30 | AU$6.85 Million ≈ $4.85 Million |
AU$-7.94 Million ≈ $-5.62 Million |
-1.158x | +23.76% |
| 2015-06-30 | AU$4.22 Million ≈ $2.98 Million |
AU$-6.41 Million ≈ $-4.53 Million |
-1.519x | -21.27% |
| 2014-06-30 | AU$5.53 Million ≈ $3.91 Million |
AU$-6.92 Million ≈ $-4.90 Million |
-1.253x | -80.71% |
| 2013-06-30 | AU$10.46 Million ≈ $7.40 Million |
AU$-7.25 Million ≈ $-5.13 Million |
-0.693x | -39.03% |
| 2012-06-30 | AU$8.55 Million ≈ $6.05 Million |
AU$-4.27 Million ≈ $-3.02 Million |
-0.499x | -189.70% |
| 2011-06-30 | AU$16.99 Million ≈ $12.02 Million |
AU$-2.92 Million ≈ $-2.07 Million |
-0.172x | +57.73% |
| 2010-06-30 | AU$3.98 Million ≈ $2.81 Million |
AU$-1.62 Million ≈ $-1.15 Million |
-0.407x | +39.77% |
| 2009-06-30 | AU$6.93 Million ≈ $4.91 Million |
AU$-4.69 Million ≈ $-3.32 Million |
-0.676x | -137.36% |
| 2008-06-30 | AU$12.96 Million ≈ $9.17 Million |
AU$-3.69 Million ≈ $-2.61 Million |
-0.285x | +65.16% |
| 2007-06-30 | AU$10.98 Million ≈ $7.77 Million |
AU$-8.97 Million ≈ $-6.35 Million |
-0.818x | +7.29% |
| 2006-06-30 | AU$11.15 Million ≈ $7.89 Million |
AU$-9.83 Million ≈ $-6.96 Million |
-0.882x | -26.70% |
| 2004-06-30 | AU$8.66 Million ≈ $6.13 Million |
AU$-6.03 Million ≈ $-4.26 Million |
-0.696x | -202.25% |
| 2003-06-30 | AU$8.25 Million ≈ $5.83 Million |
AU$-1.90 Million ≈ $-1.34 Million |
-0.230x | -80.03% |
| 2002-06-30 | AU$4.53 Million ≈ $3.21 Million |
AU$-579.75K ≈ $-410.21K |
-0.128x | +15.36% |
| 2001-06-30 | AU$5.38 Million ≈ $3.81 Million |
AU$-813.24K ≈ $-575.42K |
-0.151x | +38.59% |
| 1999-06-30 | AU$1.10 Million ≈ $781.22K |
AU$-271.66K ≈ $-192.22K |
-0.246x | -79.20% |
| 1997-06-30 | AU$4.98 Million ≈ $3.52 Million |
AU$-683.59K ≈ $-483.68K |
-0.137x | -15.69% |
| 1996-06-30 | AU$4.48 Million ≈ $3.17 Million |
AU$-532.00K ≈ $-376.42K |
-0.119x | +8.92% |
| 1995-06-30 | AU$5.82 Million ≈ $4.12 Million |
AU$-758.00K ≈ $-536.33K |
-0.130x | -1841.18% |
| 1994-06-30 | AU$6.55 Million ≈ $4.63 Million |
AU$49.00K ≈ $34.67K |
0.007x | -- |
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more